Alain J Cohen's most recent trade in C4 Therapeutics Inc was a trade of 388 Common Stock done at an average price of $26.5 . Disclosure was reported to the exchange on April 4, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
C4 Therapeutics Inc | Alain J. Cohen | Director | Grant, award, or other acquisition of securities at price $ 26.46 per share. | 04 Apr 2022 | 388 | 928 | - | 26.5 | 10,266 | Common Stock |
C4 Therapeutics Inc | Alain J. Cohen | Director | Grant, award, or other acquisition of securities at price $ 31.58 per share. | 04 Jan 2022 | 318 | 540 | - | 31.6 | 10,042 | Common Stock |
C4 Therapeutics Inc | Alain J. Cohen | Director | Grant, award, or other acquisition of securities at price $ 44.99 per share. | 04 Oct 2021 | 222 | 222 | - | 45.0 | 9,988 | Common Stock |
C4 Therapeutics Inc | Alain J. Cohen | Director | Grant, award, or other acquisition of securities at price $ 39.72 per share. | 02 Jul 2021 | 251 | 517 | - | 39.7 | 9,970 | Common Stock |
C4 Therapeutics Inc | Alain J. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
C4 Therapeutics Inc | Alain J. Cohen | Director | Other type of transaction at price $ 0.00 per share. | 14 Jun 2021 | 61,877 | 62,143 | - | 0 | Common Stock | |
C4 Therapeutics Inc | Alain J. Cohen | Director | Other type of transaction at price $ 0.00 per share. | 14 Jun 2021 | 22,598 | 1,741,930 | - | 0 | Common Stock | |
C4 Therapeutics Inc | Alain J. Cohen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 37.51 per share. | 05 Apr 2021 | 266 | 266 | - | 37.5 | 9,978 | Common Stock |
C4 Therapeutics Inc | Alain J. Cohen | Director, Ten Percent Owner | 06 Oct 2020 | 20,952,403 | 0 | - | - | Series B Preferred Stock | ||
C4 Therapeutics Inc | Alain J. Cohen | Director, Ten Percent Owner | 06 Oct 2020 | 12,500,000 | 0 | - | - | Series A Preferred Stock | ||
C4 Therapeutics Inc | Alain J. Cohen | Director, Ten Percent Owner | 06 Oct 2020 | 2,484,425 | 2,484,425 | - | - | Common Stock | ||
C4 Therapeutics Inc | Alain J. Cohen | Director, Ten Percent Owner | 06 Oct 2020 | 2,000,000 | 0 | - | - | Series Seed Preferred Stock | ||
C4 Therapeutics Inc | Alain J. Cohen | Director, Ten Percent Owner | 06 Oct 2020 | 1,482,183 | 1,719,332 | - | - | Common Stock | ||
C4 Therapeutics Inc | Alain J. Cohen | Director, Ten Percent Owner | 06 Oct 2020 | 237,149 | 237,149 | - | - | Common Stock | ||
C4 Therapeutics Inc | Alain J. Cohen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 17,786 | 17,786 | - | - | Stock Option (Right to Buy) |